Title : A cyclin-dependent kinase inhibitor, dinaciclib in preclinical treatment models of thyroid cancer.

Pub. Date : 2017

PMID : 28207834






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Dinaciclib decreased CDK1, cyclin B1, and Aurora A expression, induced cell cycle arrest in the G2/M phase, and induced accumulation of prophase mitotic cells. dinaciclib aurora kinase A Homo sapiens